Rupesh R. Kotecha MD
Radiation Oncologist, Chief of Radiosurgery, and Director of CNS Metastasis Program, Miami Cancer Institute, Baptist Health South Florida; Associate Professor, FIU Herbert Wertheim College of Medicine, Miami, Florida; Adjunct Faculty at Memorial Sloan Kettering, New York, New YorkRupesh Kotecha, MD, is a board-certified radiation oncologist and Chief of Radiosurgery in the Department of Radiation Oncology and Director of the Central Nervous System (CNS) Metastasis program at Miami Cancer Institute. He is also an Adjunct Faculty at Memorial Sloan Kettering at New York. He has specialized training and experience in utilizing the latest techniques in radiation therapy for both cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiotherapy, including CyberKnife, LINAC-based, and GammaKnife radiosurgery, and stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR). He also specializes in advanced radiation therapy treatment techniques, including re-irradiation, proton beam radiotherapy, and MR-guided radiation therapy. During medical school, Dr. Kotecha was inducted into the Alpha Omega Alpha Honor Medical Society, an organization that recognizes excellence in scholarship and the profession of medicine. He has been an invited speaker at numerous national and international symposiums, and has published multiple book chapters and over 75 articles in peer-reviewed journals, including the Journal of Clinical Oncology, International Journal of Radiation Oncology Biology Physics, Cancer, and Practical Radiation Oncology. His research bandwidth spans investigator initiated trials to multi-center trials to national cooperative group clinical protocols. Dr. Kotecha serves as the CNS co-chair for the Proton Collaborative Group , coordinates the NCI Glioblastoma Clinical Working Group, and is a course director for the annual Miami Brain Symposium. He is an editorial contributor and advisory board member on the topic of brain cancer for Practice Update, an online resource for healthcare providers throughout the United States and around the world.
Specialty: Radiation Oncology
Procedures Performed:
- 3-D conformal radiotherapy
- Brachytherapy
- External beam radiotherapy
- Gamma Knife radiosurgery
- Cyberknife radiosurgery
- Image-guided radiation therapy
- Intensity modulated radiation therapy
- Stereotactic body radiotherapy
- Stereotactic ablative radiotherapy
- Re-irradiation
- Spatially fractionated radiotherapy
- MR-guided radiotherapy
- Proton beam radiotherapy
- Cardiac radiosurgery
Education, Fellowship, & Training
Medical School – Michigan State University College of Human Medicine, East Lansing, Mich.
Residency – Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio
Disclosures
Honoraria from Accuray Inc., Elekta AB, ViewRay Inc., Novocure Inc., Elsevier Inc., and Brainlab and institutional research funding from Medtronic Inc., Blue Earth Diagnostics Ltd., Novocure Inc., GT Medical Technologies, AstraZeneca, Exelixis, ViewRay Inc., and Brainlab.
Recent Contributions to PracticeUpdate:
- CS-131 for Operable Intracranial Neoplasms
- 2021 Top Story in Brain Cancer: Spine Stereotactic Radiosurgery: Randomized Evidence to Guide Clinical Practice
- ESMO 2021: Recommendations From Dr. Rupesh Kotecha for Lung and Brain Cancer
- Stereotactic Radiosurgery for Brain Metastases From SCLC Without Prior Whole-Brain Radiotherapy
- Strategies to Preserve Neurocognition in Patients With Primary Gliomas
- Tumor Control and Risk of Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastasis
- Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves OS in High-Risk Metastatic NSCLC
- Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain
- Tumor Control Probability of Radiosurgery and Fractionated SRS for Brain Metastases
- Memory in Low-Grade Glioma Patients Treated With Radiotherapy or Temozolomide